{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:30:27Z","timestamp":1794105027600,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2313-B-A49 -001-MY3"],"award-info":[{"award-number":["NSTC 113-2313-B-A49 -001-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["114DN04"],"award-info":[{"award-number":["114DN04"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024990","name":"National Yang Ming Chiao Tung University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024990","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>During liver injury, early pathological changes may go unnoticed, delaying the diagnosis until the disease has advanced to stages such as fibrosis, cirrhosis, or hepatocellular carcinoma. Hepatic fibrosis is a sign of long-term liver injury that leads toward permanent liver damage. It involves the buildup of too much extracellular matrix (ECM) and is activated by hepatic stellate cells (HSCs). The transforming growth factor-\u03b21 (TGF-\u03b21)\/SMAD pathway is central to this process, which shows great potential for therapeutic strategies. Therefore, we investigated the therapeutic potential of microRNA (miRNA)-mediated regulation of fibrogenesis by using zebrafish models. A group of fibrosis-related miRNAs was identified and used to generate transgenic zebrafish lines. Fibrosis was induced via doxycycline (DOX)-controlled overexpression of TGF-\u03b21a, and the antifibrotic efficacy of miRNAs was evaluated. Quantitative real-time PCR showed a marked downregulation of the target miRNAs, accompanied by decreased expression of fibrotic markers. Next, we confirmed that TGF-\u03b21a, GREM1, and \u03b1-SMA protein levels were decreasing. Histological staining revealed improved liver structure and diminished collagen deposition. These findings indicate that through manipulating the miRNA expressions, we can effectively disrupt TGF-\u03b2-induced fibrogenesis, inactivate HSC, inhibit ECM remodeling, and attenuate liver fibrosis, and highlight the potential of miRNA-based therapeutic strategies for early intervention in liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key messages<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Establishment of an\n                            <jats:italic>in vivo<\/jats:italic>\n                            model for developing an inducible miRNA expression system in zebrafish.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Predicting and evaluating targeted miRNAs that attenuate TGF-\u03b2-induced hepatic fibrosis.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Elucidate the potential mechanism for fibrosis that may be a strategy for future therapies.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>MicroRNA-mediated modulation attenuates hepatic fibrosis by coordinately suppressing the TGF-\u03b2\/SMAD signaling pathway, hepatic stellate cell activation, and extracellular matrix deposition. Protein-level validation confirms reduced phosphorylation of Smad2 and decreased expression of key fibrotic markers, including \u03b1-SMA, collagen I, and fibronectin. These findings highlight a multi-target regulatory mechanism through which miRNAs exert antifibrotic effects at the systems level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00109-026-02672-y","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:14:52Z","timestamp":1777558492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fibrotic microRNAs in the suppression of HSC activation and ECM deposition to facilitate the regression of hepatic fibrosis in zebrafish"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-0633","authenticated-orcid":false,"given":"Yu-Heng","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Kuang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Tsui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semon","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-3878","authenticated-orcid":false,"given":"Guor Mour","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2672_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126649","author":"E Binatti","year":"2022","unstructured":"Binatti E, Gerussi A, Barisani D, Invernizzi P (2022) The role of macrophages in liver fibrosis: new therapeutic opportunities. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23126649","journal-title":"Int J Mol Sci"},{"key":"2672_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA (2014) Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14:181\u2013194","journal-title":"Nat Rev Immunol"},{"key":"2672_CR3","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX (2016) Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 22:10512\u201310522","journal-title":"World J Gastroenterol"},{"key":"2672_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25:195\u2013206","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2672_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14:397\u2013411","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2672_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","volume":"2","author":"C Ortiz","year":"2021","unstructured":"Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J (2021) Extracellular matrix remodeling in chronic liver disease. Curr Tissue Microenviron Rep 2:41\u201352","journal-title":"Curr Tissue Microenviron Rep"},{"key":"2672_CR7","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","volume":"66","author":"N Ikenaga","year":"2017","unstructured":"Ikenaga N, Peng ZW, Vaid KA, Liu SB, Yoshida S, Sverdlov DY, Mikels-Vigdal A, Smith V, Schuppan D, Popov YV (2017) Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut 66:1697\u20131708","journal-title":"Gut"},{"key":"2672_CR8","doi-asserted-by":"publisher","first-page":"20964","DOI":"10.1074\/jbc.M109.094136","volume":"285","author":"HM Rodriguez","year":"2010","unstructured":"Rodriguez HM, Vaysberg M, Mikels A, McCauley S, Velayo AC, Garcia C, Smith V (2010) Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor. J Biol Chem 285:20964\u201320974","journal-title":"J Biol Chem"},{"key":"2672_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"key":"2672_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7861\/clinmedicine.11-2-179","volume":"11","author":"J Fallowfield","year":"2011","unstructured":"Fallowfield J, Hayes P (2011) Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Clin Med (Lond) 11:179\u2013183","journal-title":"Clin Med (Lond)"},{"key":"2672_CR11","doi-asserted-by":"crossref","unstructured":"Dewidar B, Meyer C, Dooley S, and Meindl-Beinker AN (2019) TGF-beta in hepatic stellate cell activation and liver fibrogenesis-Updated. Cells 8(11), 1419","DOI":"10.3390\/cells8111419"},{"key":"2672_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","volume":"47","author":"B Hinz","year":"2015","unstructured":"Hinz B (2015) The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship. Matrix Biol 47:54\u201365","journal-title":"Matrix Biol"},{"key":"2672_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jb\/mvs089","volume":"152","author":"M Horiguchi","year":"2012","unstructured":"Horiguchi M, Ota M, Rifkin DB (2012) Matrix control of transforming growth factor-beta function. J Biochem 152:321\u2013329","journal-title":"J Biochem"},{"key":"2672_CR14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2353\/ajpath.2009.090393","volume":"175","author":"SL Nishimura","year":"2009","unstructured":"Nishimura SL (2009) Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol 175:1362\u20131370","journal-title":"Am J Pathol"},{"key":"2672_CR15","first-page":"1375","volume":"25","author":"ES Kim","year":"2004","unstructured":"Kim ES, Kim MS, Moon A (2004) TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 25:1375\u20131382","journal-title":"Int J Oncol"},{"key":"2672_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-26","volume":"12","author":"LR Gomes","year":"2012","unstructured":"Gomes LR, Terra LF, Wailemann RA, Labriola L, Sogayar MC (2012) TGF-beta1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1\/2 in highly invasive breast cancer cells. BMC Cancer 12:26","journal-title":"BMC Cancer"},{"key":"2672_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.200606058","volume":"175","author":"G Ge","year":"2006","unstructured":"Ge G, Greenspan DS (2006) Bmp1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 175:111\u2013120","journal-title":"J Cell Biol"},{"key":"2672_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/2193-1801-3-221","volume":"3","author":"M Hara","year":"2014","unstructured":"Hara M, Kirita A, Kondo W, Matsuura T, Nagatsuma K, Dohmae N, Ogawa S, Imajoh-Ohmi S, Friedman SL, Rifkin DB, Kojima S (2014) LAP degradation product reflects plasma kallikrein-dependent TGF-beta activation in patients with hepatic fibrosis. Springerplus 3:221","journal-title":"Springerplus"},{"key":"2672_CR19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N (2020) Transforming growth factor-beta in tissue fibrosis. J Exp Med 217:e20190103","journal-title":"J Exp Med"},{"key":"2672_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng XH, Derynck R (2005) Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659\u2013693","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2672_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/39369","volume":"389","author":"A Nakao","year":"1997","unstructured":"Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389:631\u2013635","journal-title":"Nature"},{"key":"2672_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI6094","volume":"104","author":"A Nakao","year":"1999","unstructured":"Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I (1999) Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104:5\u201311","journal-title":"J Clin Invest"},{"key":"2672_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2022.113772","volume":"249","author":"Z Sun","year":"2022","unstructured":"Sun Z, Li L, Yan Z, Zhang L, Zang G, Qian Y, Wang Z (2022) Circadian rhythm disorders elevate macrophages cytokines release and promote multiple tissues\/organs dysfunction in mice. Physiol Behav 249:113772","journal-title":"Physiol Behav"},{"key":"2672_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00856-w","volume":"12","author":"X Zhao","year":"2022","unstructured":"Zhao X, Chen J, Sun H, Zhang Y, Zou D (2022) New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction. Cell Biosci 12:117","journal-title":"Cell Biosci"},{"key":"2672_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jablonska-Trypuc","year":"2016","unstructured":"Jablonska-Trypuc A, Matejczyk M, Rosochacki S (2016) Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem 31:177\u2013183","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2672_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1357-2725(96)00118-5","volume":"29","author":"JP Iredale","year":"1997","unstructured":"Iredale JP (1997) Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 29:43\u201354","journal-title":"Int J Biochem Cell Biol"},{"key":"2672_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","volume":"44-46","author":"V Arpino","year":"2015","unstructured":"Arpino V, Brock M, Gill SE (2015) The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 44\u201346:247\u2013254","journal-title":"Matrix Biol"},{"key":"2672_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0752-1","volume":"9","author":"L Ma","year":"2018","unstructured":"Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M, Men R, Li P, Dong B, Liu L, Fu X, Xu H, Aqeilan RI, Wei YQ, Yang L, Peng Y (2018) Microrna-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis 9:718","journal-title":"Cell Death Dis"},{"key":"2672_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169380","author":"C Ariyachet","year":"2022","unstructured":"Ariyachet C, Chuaypen N, Kaewsapsak P, Chantaravisoot N, Jindatip D, Potikanond S, Tangkijvanich P (2022) Microrna-223 suppresses human hepatic stellate cell activation partly via regulating the actin cytoskeleton and alleviates fibrosis in organoid models of liver injury. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169380","journal-title":"Int J Mol Sci"},{"key":"2672_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.omtn.2023.07.012","volume":"33","author":"S Bala","year":"2023","unstructured":"Bala S, Zhuang Y, Nagesh PT, Catalano D, Zivny A, Wang Y, Xie J, Gao G, Szabo G (2023) Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling. Mol Ther Nucleic Acids 33:413\u2013427","journal-title":"Mol Ther Nucleic Acids"},{"key":"2672_CR31","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1261\/rna.2414110","volume":"16","author":"MS Ebert","year":"2010","unstructured":"Ebert MS, Sharp PA (2010) Microrna sponges: progress and possibilities. RNA 16:2043\u20132050","journal-title":"RNA"},{"key":"2672_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microrna targets. Cell 115:787\u2013798","journal-title":"Cell"},{"key":"2672_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","volume":"214","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Lin CY, Cheng K (2019) SiRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res 214:17\u201329","journal-title":"Transl Res"},{"key":"2672_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","volume":"129","author":"Q Su","year":"2018","unstructured":"Su Q, Kumar V, Sud N, Mahato RI (2018) Micrornas in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Adv Drug Deliv Rev 129:54\u201363","journal-title":"Adv Drug Deliv Rev"},{"key":"2672_CR35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbalip.2011.06.011","volume":"1811","author":"GM Her","year":"2011","unstructured":"Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, Chan SK, Pai WY (2011) Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta 1811:536\u2013548","journal-title":"Biochim Biophys Acta"},{"key":"2672_CR36","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbalip.2013.02.002","volume":"1831","author":"GM Her","year":"2013","unstructured":"Her GM, Pai WY, Lai CY, Hsieh YW, Pang HW (2013) Ubiquitous transcription factor YY1 promotes zebrafish liver steatosis and lipotoxicity by inhibiting CHOP-10 expression. Biochim Biophys Acta 1831:1037\u20131051","journal-title":"Biochim Biophys Acta"},{"key":"2672_CR37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.bbalip.2018.04.009","volume":"1863","author":"CY Lai","year":"2018","unstructured":"Lai CY, Lin CY, Hsu CC, Yeh KY, Her GM (2018) Liver-directed microrna-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish. Biochim Biophys Acta Mol Cell Biol Lipids 1863:844\u2013856","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2672_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123434","author":"YW Tsai","year":"2021","unstructured":"Tsai YW, Jeng KS, He MK, Hsieh YW, Lai HH, Lai CY, Huang CC, Chang CF, Huang CT, Her GM (2021) MXD3 promotes obesity and the androgen receptor signaling pathway in gender-disparity hepatocarcinogenesis. Cells. https:\/\/doi.org\/10.3390\/cells10123434","journal-title":"Cells"},{"key":"2672_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbrc.2018.12.098","volume":"509","author":"C Yan","year":"2019","unstructured":"Yan C, Yang Q, Gong Z (2019) Transgenic expression of tgfb1a induces hepatic inflammation, fibrosis and metastasis in zebrafish. Biochem Biophys Res Commun 509:175\u2013181","journal-title":"Biochem Biophys Res Commun"},{"key":"2672_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25743-8","volume":"8","author":"M Zhu","year":"2018","unstructured":"Zhu M, Wang Q, Zhou W, Liu T, Yang L, Zheng P, Zhang L, Ji G (2018) Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD. Sci Rep 8:7628","journal-title":"Sci Rep"},{"key":"2672_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.706341","volume":"12","author":"Y Tai","year":"2021","unstructured":"Tai Y, Zhao C, Lan T, Zhang L, Xiao Y, Tong H, Liu R, Tang C, Gao J (2021) Integrated analysis of hepatic miRNA and mRNA expression profiles in the spontaneous reversal process of liver fibrosis. Front Genet 12:706341","journal-title":"Front Genet"},{"key":"2672_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071023","author":"TJ Steeman","year":"2021","unstructured":"Steeman TJ, Rubiolo JA, Sanchez LE, Calcaterra NB, Weiner AMJ (2021) Conservation of zebrafish MicroRNA-145 and its role during neural crest cell development. Genes (Basel). https:\/\/doi.org\/10.3390\/genes12071023","journal-title":"Genes (Basel)"},{"key":"2672_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35040556","volume":"408","author":"AE Pasquinelli","year":"2000","unstructured":"Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86\u201389","journal-title":"Nature"},{"key":"2672_CR44","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1002\/dvdy.21343","volume":"236","author":"KM Kwan","year":"2007","unstructured":"Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB (2007) The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236:3088\u20133099","journal-title":"Dev Dyn"},{"key":"2672_CR45","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1073\/pnas.1716713115","volume":"115","author":"H Sanchez-Iranzo","year":"2018","unstructured":"Sanchez-Iranzo H, Galardi-Castilla M, Sanz-Morejon A, Gonzalez-Rosa JM, Costa R, Ernst A, Sainz de Aja J, Langa X, Mercader N (2018) Transient fibrosis resolves via fibroblast inactivation in the regenerating zebrafish heart. Proc Natl Acad Sci U S A 115:4188\u20134193","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2672_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5625\/lar.2018.34.4.147","volume":"34","author":"H Kim","year":"2018","unstructured":"Kim H, Kim M, Im SK, Fang S (2018) Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes. Lab Anim Res 34:147\u2013159","journal-title":"Lab Anim Res"},{"key":"2672_CR47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1242\/dmm.003087","volume":"2","author":"K Anastassiadis","year":"2009","unstructured":"Anastassiadis K, Fu J, Patsch C, Hu S, Weidlich S, Duerschke K, Buchholz F, Edenhofer F, Stewart AF (2009) Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis Model Mech 2:508\u2013515","journal-title":"Dis Model Mech"},{"key":"2672_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.gene.2011.03.003","volume":"480","author":"X Li","year":"2011","unstructured":"Li X, Gibson G, Kim JS, Kroin J, Xu S, van Wijnen AJ, Im HJ (2011) MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 480:34\u201341","journal-title":"Gene"},{"key":"2672_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1074\/jbc.M609383200","volume":"282","author":"GK Scott","year":"2007","unstructured":"Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC (2007) Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282:1479\u20131486","journal-title":"J Biol Chem"},{"key":"2672_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0065-230X(08)60101-3","volume":"71","author":"D Naor","year":"1997","unstructured":"Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71:241\u2013319","journal-title":"Adv Cancer Res"},{"key":"2672_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG (2011) The microrna miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17:211\u2013215","journal-title":"Nat Med"},{"key":"2672_CR52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s13258-024-01520-y","volume":"46","author":"SH Han","year":"2024","unstructured":"Han SH, Mo JS, Yun KJ, Chae SC (2024) Microrna 429 regulates MMPs expression by modulating TIMP2 expression in colon cancer cells and inflammatory colitis. Genes & Genomics 46:763\u2013774","journal-title":"Genes & Genomics"},{"key":"2672_CR53","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.febslet.2013.12.028","volume":"588","author":"M Zhu","year":"2014","unstructured":"Zhu M, Zhang N, He S, Lui Y, Lu G, Zhao L (2014) Microrna-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. FEBS Lett 588:600\u2013607","journal-title":"FEBS Lett"},{"key":"2672_CR54","first-page":"841","volume":"52","author":"H Nagai","year":"2018","unstructured":"Nagai H, Hasegawa S, Uchida F, Terabe T, Ishibashi Kanno N, Kato K, Yamagata K, Sakai S, Kawashiri S, Sato H, Yanagawa T, Bukawa H (2018) Microrna-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP-2 expression. Int J Oncol 52:841\u2013850","journal-title":"Int J Oncol"},{"key":"2672_CR55","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.28577","volume":"64","author":"AK Kai","year":"2016","unstructured":"Kai AK, Chan LK, Lo RC, Lee JM, Wong CC, Wong JC, Ng IO (2016) Down-regulation of TIMP2 by HIF-1alpha\/miR-210\/HIF-3alpha regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Hepatology 64:473\u2013487","journal-title":"Hepatology"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02672-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02672-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02672-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:02:16Z","timestamp":1777564936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02672-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2672"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02672-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Animal Research Committee of the National Yang Ming Chiao Tung University. All procedures followed the Guide for the Care and Use of Laboratory Animals (NIH publication, 85\u201323, revised 1996) and the guidelines of the Animal Welfare Act, Taiwan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"70"}}